Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Oncology [Oncology] NLMUID: 0135054"" wg kryterium: JN


Tytuł :
Systemic Effects of Radiation Therapy-Induced Abscopal Responses in Patients with Advanced Lung Cancer.
Autorzy :
D'Andrea MA; University Cancer and Diagnostic Centers, Houston, Texas, USA.
Reddy GK; University Cancer and Diagnostic Centers, Houston, Texas, USA, .
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Nov 20, pp. 1-14. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Autorzy :
Yamashige D; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Kawamura Y; Department of Hepatology, Toranomon Hospital, Tokyo, Japan, .; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan, .
Kobayashi M; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Shindoh J; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.; Hepatobiliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Kobayashi Y; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.; Hepatobiliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Okubo S; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.; Hepatobiliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Muraishi N; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.; Hepatobiliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Kajiwara A; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Iritani S; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Fujiyama S; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Hosaka T; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Saitoh S; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Sezaki H; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Akuta N; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Suzuki F; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Suzuki Y; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Ikeda K; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Arase Y; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Hashimoto M; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.; Hepatobiliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Kumada H; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Nov 18, pp. 1-8. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cholangiocarcinoma Evaluation via Imaging and Artificial Intelligence.
Autorzy :
Yang CM; Department of Radiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Shu J; Department of Radiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China, .
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Nov 04, pp. 1-12. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights.
Autorzy :
De Renzi G; Department of Molecular Medicine, Cancer Liquid Biopsy Unit, Sapienza University of Rome, Rome, Italy.
Gaballo G; Department of Molecular Medicine, Cancer Liquid Biopsy Unit, Sapienza University of Rome, Rome, Italy.
Gazzaniga P; Department of Molecular Medicine, Cancer Liquid Biopsy Unit, Sapienza University of Rome, Rome, Italy.
Nicolazzo C; Department of Molecular Medicine, Cancer Liquid Biopsy Unit, Sapienza University of Rome, Rome, Italy, .
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Oct 30, pp. 1-9. Date of Electronic Publication: 2020 Oct 30.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT.
Autorzy :
Ahopelto K; Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, .; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland, .
Saukkonen K; Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Hagström J; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Pathology and Oral Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Kauhanen S; Division of Digestive Surgery and Urology, Turku University Hospital, Turku, Finland.
Seppänen H; Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Böckelman C; Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Haglund C; Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Oct 29, pp. 1-9. Date of Electronic Publication: 2020 Oct 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Role of PD-L1 Expression during the Progression of Submucosal Gastric Cancer.
Autorzy :
Ubukata Y; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Ogata K; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Sohda M; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan, .
Yokobori T; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Shimoda Y; Department of Pathology, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Handa T; Department of Pathology, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Nakazawa N; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Kimura A; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Kogure N; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Sano A; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Sakai M; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Ogawa H; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Kuwano H; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Shirabe K; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Oyama T; Department of Pathology, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Saeki H; Department of General Surgery, Graduate School of Medical Sciences, Gunma University, Maebashi, Japan.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Oct 28, pp. 1-8. Date of Electronic Publication: 2020 Oct 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
Autorzy :
Jiang DM; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Sim HW; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Espin-Garcia O; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Chan BA; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Natori A; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Lim CH; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Moignard S; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Chen EX; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Liu G; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Darling G; Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Swallow CJ; Department of Surgical Oncology, Mount Sinai Hospital/Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Brar S; Department of Surgical Oncology, Mount Sinai Hospital/Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Brierley J; Radiation Medicine Program, Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Ringash J; Radiation Medicine Program, Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Wong R; Radiation Medicine Program, Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Kim J; Radiation Medicine Program, Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Rogalla P; Joint Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
Hafezi-Bakhtiari S; Department of Pathology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Knox JJ; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Jang RW; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Elimova E; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada, .
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Oct 14, pp. 1-8. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study.
Autorzy :
Koda Y; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Kuribayashi K; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan, .; Department of Thoracic Oncology, Hyogo College of Medicine, Nishinomiya, Japan, .
Doi H; Department of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Kitajima K; Department of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Nakajima Y; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Ishigaki H; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Nakamura A; Division of Thoracic Surgery, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Minami T; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Takahashi R; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Yokoi T; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.; Department of Thoracic Oncology, Hyogo College of Medicine, Nishinomiya, Japan.
Kijima T; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.; Department of Thoracic Oncology, Hyogo College of Medicine, Nishinomiya, Japan.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Oct 14, pp. 1-8. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Sequencing PEComas: Viewing Unicorns through the Molecular Looking Glass.
Autorzy :
Groisberg R; Department of Melanoma/Sarcoma Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA, .
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Oct 13, pp. 1-3. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Endometrial Cancer: When Upfront Surgery Is Not an Option.
Autorzy :
Barcellini A; National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy, .
Roccio M; Department of Obstetrics and Gynecology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
Laliscia C; Department of Translational Medicine, Division of Radiation Oncology, University of Pisa, Pisa, Italy.
Zanellini F; Department of Obstetrics and Gynecology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
Pettinato D; Department of Obstetrics and Gynecology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
Valvo F; National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Mirandola A; National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Orlandi E; National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Gadducci A; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Oct 08, pp. 1-7. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas.
Autorzy :
Uchida-Kobayashi S; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan, .
Kageyama K; Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Yamamoto A; Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Ikenaga H; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Yoshida K; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Kotani K; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Kimura K; Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Odagiri N; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Hagihara A; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Fujii H; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Enomoto M; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Tamori A; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Kubo S; Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Miki Y; Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Kawada N; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Oct 08, pp. 1-6. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Autorzy :
Peltonen R; Transplantation and Liver Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, .
Hagström J; Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.; Research Programs Unit, Translational Cancer Medicine Program, University of Helsinki, Helsinki, Finland.
Tervahartiala T; Department of Oral and Maxillofacial Diseases, Helsinki University Hospital and Biomedicum Helsinki, Helsinki, Finland.
Sorsa T; Department of Oral and Maxillofacial Diseases, Helsinki University Hospital and Biomedicum Helsinki, Helsinki, Finland.; Department of Oral Diseases, Karolinska Institutet, Huddinge, Sweden.
Haglund C; Research Programs Unit, Translational Cancer Medicine Program, University of Helsinki, Helsinki, Finland.; Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Isoniemi H; Transplantation and Liver Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Programs Unit, Translational Cancer Medicine Program, University of Helsinki, Helsinki, Finland.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Oct 07, pp. 1-17. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Autorzy :
Akuta N; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan, .
Kawamura Y; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Kobayashi M; Liver Research Laboratory, Toranomon Hospital, Tokyo, Japan.
Arase Y; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Saitoh S; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Fujiyama S; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Sezaki H; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Hosaka T; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Kobayashi M; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Suzuki Y; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Suzuki F; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Ikeda K; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Kumada H; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Sep 30, pp. 1-10. Date of Electronic Publication: 2020 Sep 30.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
Autorzy :
Borreani C; Clinical Psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Alfieri S; Clinical Psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, .
Infante G; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Miceli R; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mariani P; Clinica Polispecialistica San Carlo, Paderno Dugnano, Milan, Italy.
Bosisio M; Clinical Psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Vernieri C; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Bianchi GV; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Capri G; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Sep 29, pp. 1-12. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
Autorzy :
Seol HY; Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
Kim YS; Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
Kim SJ; Department of Nuclear Medicine, College of Medicine, Pusan National University, Yangsan, Republic of Korea, .; Department of Nuclear Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea, .; BioMedical Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea, .
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Sep 25, pp. 1-9. Date of Electronic Publication: 2020 Sep 25.
Typ publikacji :
Meta-Analysis
Raport
Tytuł :
Risk Factors for Cisplatin-Induced Nephrotoxicity: A Multicenter Retrospective Study.
Autorzy :
Miyoshi T; Department of Pharmacy, National Hospital Organization Beppu Medical Center, Beppu, Japan, .
Uoi M; Department of Pharmacy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Omura F; Department of Pharmacy, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Tsumagari K; Department of Pharmacy, National Hospital Organization Miyakonojo Medical Center, Miyakonojo, Japan.
Maesaki S; Department of Pharmacy, National Hospital Organization Kumamoto Saishun Medical Center, Koushi, Japan.
Yokota C; Department of Pharmacy, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Sep 23, pp. 1-9. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI).
Autorzy :
Steffen T; Department of Surgery, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland, .
Häller L; Department of Surgery, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.
Bijelic L; Peritoneal Surface Malignancies Unit, Hospital Sant Joan Despi Moises Broggi, Barcelona, Spain.
Glatzer M; Department of Radiation Oncology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.
Glehen O; Department of Digestive Surgery, Hospices Civils de Lyon, Lyon, France.
Goéré D; Department of Surgery, Gustave Roussy Institute, Villejuif, France.
de Hingh I; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
Li Y; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Beijing, China.
Moran BJ; Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom.
Morris DL; Department of Surgery, St. George Hospital and University of New South Wales, Sydney, New South Wales, Australia.
Piso P; Department of Surgical Oncology, Hospital Barmherzige Brüder Regensburg, Regensburg, Germany.
Quadros CA; Surgical Oncology Unit, São Rafael Hospital, Salvador, Brazil.
Rau B; Department of General Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sugarbaker P; Peritoneal Surface Oncology Unit, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
Yonemura Y; Peritoneal Metastasis Center, Kishiwada Tokushukai Hospital, Osaka, Japan.
Putora PM; Department of Radiation Oncology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.; Department of Radiation Oncology, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Sep 11, pp. 1-8. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Diagnostic Capability of Cerebrospinal Fluid-Placental Alkaline Phosphatase Value in Intracranial Germ Cell Tumor.
Autorzy :
Okamoto M; Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Yamaguchi S; Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan, .
Ishi Y; Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Motegi H; Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Mori T; Department of Oral Radiology, Hokkaido University Hospital, Sapporo, Japan.; Department of Radiation Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Hashimoto T; Department of Radiation Medical Science and Engineering, Hokkaido University Graduate School of Medicine, Sapporo, Japan.; Department of Radiation Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Terashita Y; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Hirabayashi S; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Sugiyama M; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Iguchi A; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Cho Y; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Manabe A; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Houkin K; Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Sep 09, pp. 1-9. Date of Electronic Publication: 2020 Sep 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment.
Autorzy :
Tseng JS; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Hsu KH; Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Zheng ZR; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Yang TY; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Chen KC; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan.
Huang YH; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Su KY; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yu SL; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Center of Genomic Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Pathology and Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Center for Optoelectronic Biomedicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chang GC; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, .; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, .; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan, .; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan, .; School of Medicine, Chung Shan Medical University, Taichung, Taiwan, .; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, .
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Sep 07, pp. 1-9. Date of Electronic Publication: 2020 Sep 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study).
Autorzy :
Nakamura M; Second Department of Surgery, Wakayama Medical University, Wakayama, Japan, .
Ojima T; Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.
Katsuda M; Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.
Hayata K; Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.
Kitadani J; Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.
Nakamori M; Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.
Yamaue H; Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Sep 02, pp. 1-5. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies